NCT04384991View on ClinicalTrials.gov

HU007 Eye Drops in Patients With Dry Eye Syndrome

PHASE3CompletedINTERVENTIONAL
Enrollment

216

Participants

Timeline

Start Date

May 3, 2019

Primary Completion Date

December 5, 2019

Study Completion Date

December 5, 2019

Conditions
Dry Eye Syndromes
Interventions
DRUG

HU007

Cyclosporine 0.02% with Trehalose 3%

DRUG

Restasis eye drop

Cyclosporine 0.05%

Trial Locations (1)

Unknown

Seoul National University Bundang Hospital, Seongnam

All Listed Sponsors
lead

Huons Co., Ltd.

INDUSTRY

NCT04384991 - HU007 Eye Drops in Patients With Dry Eye Syndrome | Biotech Hunter | Biotech Hunter